Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

The company recently completed a massive expansion in Durham and is acquiring a Raleigh company for billions. Join us as we honor outstanding C-Level Executives for their invaluable contributions to ...

General market weakness greeted the closing bell on Thursday on both sides of the border, as suspense reigned over whether a trade deal could be worked out between Canada and the U.S. before a Friday ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

Merck to acquire Verona Pharma for $10B, gaining Ohtuvayre, a breakthrough COPD treatment with rapid uptake since its 2024 launch.

Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease in more than a decade.

Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Friday, Apr. 2, 2021, in Durham, N.C.·Raleigh News and Observer·Casey Toth/ctoth@newsobserver.com ...

The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...

Based in New Jersey, Merck is the world’s 42nd-largest public company by market capitalization. In March, the drugmaker opened a $1 billion vaccine manufacturing facility in north Durham, at its ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...